A humanized monoclonal antibody targeting Staphylococcus aureus

Vaccine

Volumn 22, Issue SUPPL. 1, 2004, Pages

  Patti, Joseph M ^a  

^a Inhibitex Inc   (United States)

Author keywords

Adhesin; Monoclonal antibodies; MSCRAMM ; Staphylococcus aureus

Indexed keywords

ADHESIN; ANTIBIOTIC AGENT; AUREXIS; BACTERIUM ANTIBODY; CLUMPING FACTOR A PROTEIN; FIBRINOGEN; IMMUNOGLOBULIN G; METICILLIN; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 12 9; PROTEIN DERIVATIVE; TEFIBAZUMAB; UNCLASSIFIED DRUG; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; BACTEREMIA; BACTERIAL ENDOCARDITIS; BACTERIAL STRAIN; BINDING AFFINITY; CELL SURFACE; CLINICAL TRIAL; CONFERENCE PAPER; DRUG SAFETY; DRUG SCREENING; DRUG SPECIFICITY; DRUG TARGETING; HOSPITAL INFECTION; HUMAN; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; PHAGOCYTE; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; PROVOCATION TEST; SEPSIS; SEPTICEMIA; SIDE EFFECT; STAPHYLOCOCCUS INFECTION;

ADHESINS, BACTERIAL; ANIMALS; ANTIBODIES, MONOCLONAL; CROSS INFECTION; HUMANS; MICE; RABBITS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 9644259128     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2004.08.015     Document Type: Conference Paper

References (30)

1. M. Hall, and L. Lawrence Ambulatory surgery in the United States, 1996 Advance data from vital and health statistics vol. 300 1998 National Center for Health Statistics Hyattsville, MD
2. T.C. Horan, D.H. Culver, R.P. Gaynes, W.R. Jarvis, J.R. Edwards, and C.R. Reid Nosocomial infections in surgical patients in the United States January 1986-June 1992. National Nosocomial Infections Surveillance (NNIS) System Infect Control Hosp Epidemiol 14 2 1993 73 80
3. J.M. Boyce, G. Potter-Bynoe, and L. Dziobek Hospital reimbursement patterns among patients with surgical wound infections following open heart surgery Infect Control Hosp Epidemiol 11 2 1990 89 93
4. J.M. Boyce, L. Dziobek, and G. Potter-Bynoe Reimbursement for nosocomial infections Ann Intern Med 108 5 1988 776
5. K.B. Kirkland, J.P. Briggs, S.L. Trivette, WE. Wilkinson, and D.J. Sexton The impact of surgical-site infections in the 1990s: attributable mortality, excess length of hospitalization, and extra costs Infect Control Hosp Epidemiol 20 11 1999 725 730
6. J.D. Whitehouse, N.D. Friedman, K.B. Kirkland, W.J. Richardson, and D.J. Sexton The impact of surgical-site infections following orthopedic surgery at a community hospital and a university hospital: adverse quality of life, excess length of stay, and extra cost Infect Control Hosp Epidemiol 23 4 2002 183 189
7. D.H. Duckworth, and P.A. Gulig Bacteriophages: potential treatment for bacterial infections BioDrugs 16 1 2002 57 62
8. H. Donabedian Quorum sensing and its relevance to infectious diseases J Infect Dis 46 4 2003 207 214
9. C. Von Eiff, J.F. Kokai-Kun, K. Becker, and G. Peters In vitro activity of recombinant lysostaphin against staphylococcus aureus isolates from anterior nares and blood Antimicrob Agents Chemother 47 11 2003 3613 3615
10. J.A. Wu, C. Kusuma, J.J. Mond, and J.F. Kokai-Kun Lysostaphin disrupts Staphylococcus aureus and Staphylococcus epidermidis biofilms on artificial surfaces Antimicrob Agents Chemother 47 11 2003 3407 3414
11. M.J. Richards, J.R. Edwards, D.H. Culver, and R.P. Gaynes Nosocomial infections in medical intensive care units in the United States. National Nosocomial Infections Surveillance System Crit Care Med 27 5 1999 887 892
12. C.A. Morin, and J.L. Hadler Population-based incidence and characteristics of community-onset Staphylococcus aureus infections with bacteremia in 4 metropolitan Connecticut areas, 1998 J Infect Dis 184 8 2001 1029 1034
13. S. Chang, D.M. Sievert, and J.C. Hageman Infection with vancomycin-resistant Staphylococcus aureus containing the vanA resistance gene N Engl J Med 348 14 2003 1342 1347
14. Staphylococcus aureus resistant to vancomycin - United States, 2002. MMWR Morb Mortal Wkly Rep 2002; 51(26):565-67.
15. J.C. Lee Staphylococcus aureus vaccine R. Ellis B. Brodeur New bacterial vaccines 2003 Kluwer Academic/Plenum Press pp. 283-93
16. J. Lee Development of antistaphylococcal vaccines Curr Infect Dis Rep 3 2001 517 524
17. D. McDevitt, P. Francois, P. Vaudaux, and T.J. Foster Molecular characterization of the clumping factor (fibrinogen receptor) of Staphylococcus aureus Mol Microbiol 11 2 1994 237 248
18. D. McDevitt, P. Vaudaux, and T.J. Foster Genetic evidence that bound coagulase of Staphylococcus aureus is not clumping factor Infect Immun 60 4 1992 1514 1523
19. I.R. Siboo, A.L. Cheung, A.S. Bayer, and P.M. Sullam Clumping factor A mediates binding of Staphylococcus aureus to human platelets Infect Immun 69 5 2001 3120 3127
20. P. Moreillon, J.M. Entenza, and P. Francioli Role of Staphylococcus aureus coagulase and clumping factor in pathogenesis of experimental endocarditis Infect Immun 63 12 1995 4738 4743
21. Y.A. Que, J.A. Haefliger, P. Francioli, and P. Moreillon Expression of Staphylococcus aureus clumping factor A in Lactococcus lactis subsp. cremoris using a new shuttle vector Infect Immun 68 6 2000 3516 3522
22. P. Stutzmann Meier, J.M. Entenza, P. Vaudaux, P. Francioli, M.P. Glauser, and P. Moreillon Study of Staphylococcus aureus pathogenic genes by transfer and expression in the less virulent organism Streptococcus gordonii Infect Immun 69 2 2001 657 664
23. C. Wolz, C. Goerke, R. Landmann, W. Zimmerli, and U. Fluckiger Transcription of clumping factor A in attached and unattached Staphylococcus aureus in vitro and during device-related infection Infect Immun 70 6 2002 2758 2762
24. P. Colque-Navarro, M. Palma, B. Soderquist, J.I. Flock, and R. Mollby Antibody responses in patients with staphylococcal septicemia against two Staphylococcus aureus fibrinogen binding proteins: clumping factor and an extracellular fibrinogen binding protein Clin Diagn Lab Immunol 7 1 2000 14 20
25. J. Vernachio, A. Bayer, and T. Le Anti-clumping factor a immunoglobulin reduces the duration of methicillin-resistant Staphylococcus aureus bacteremia in an experimental model of infective endocarditis Antimicrob Agents Chemother 47 11 2003 3400 3406
26. ® protein clumping factor A Infect Immun 71 12 2003 6864 6870
27. A. Rennermalm, Y.H. Li, L. Bohaufs, C. Jarstrand, A. Brauner, F.R. Brennan, and J.I. Flock Antibodies against a truncated Staphylococcus aureus fibronectin-binding protein protect against dissemination of infection in the rat Vaccine 19 2001 3376 3383
28. I.M. Nilsson, J.M. Patti, T. Bremell, M. Hook, and A. Tarkowski Vaccination with a recombinant fragment of collagen adhesin provides protection against Staphylococcus aureus-mediated septic death J Clin Invest 101 1998 2640 2649
29. Josefsson E, Hartford O, O'Brien L, Patti JM, Foster TJ. 2001. Protection against experimental Staphylococcus aureus arthritis by vaccination with clumping factor A, a novel virulence determinant. J Infect Dis.
30. B. Rozalska, and T. Wadstrom Protective opsonic activity of antibodies against fibronectin-binding proteins (FnBPs) of Staphylococcus aureus Scandinavian Journal of Immunology 37 1993 575 580